Breaking News

Morphotek Opens Manufacturing Plant

Invests $80 million in cGMP facility in Exton, PA

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Morphotek, Inc., a wholly-owned subsidiary of Eisai Co., Ltd., has opened a new pilot manufacturing plant in Exton, PA for the production of biologic-based therapeutics to support its early-stage clinical trials. The company invested $80 million in the 60,000-sq.-ft. cGMP facility to maximize efficiencies for its product development process.   The facility will begin production operations in late 2012 and GMP manufacturing in 2013. The company has hired 23 new employees and expects additional jo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters